-- 根據週四深圳證券交易所披露的信息，河北常山生化藥業（深交所代碼：300255）已獲得白俄羅斯藥品監管機構頒發的達肝素鈉注射液藥品註冊證書。 該藥用於治療急性深部靜脈栓塞和不穩定型冠狀動脈疾病。
Related Articles
Japan
US 10-Yr Treasury Yield Slips 1.8 Basis Points to 4.34%, Extending Drop From Highest in About a Month
Asia
Mencast Grants Nearly 3 Million Shares Under Performance Award Scheme
Mencast (SGX:5NF) granted 2.9 million shares under the company's performance share award scheme, according to a Thursday filing with the Singapore Exchange.The awards will vest immediately upon granting, the filing stated.
$SGX:5NF
Mining & Metals
Earnings Flash (MFI.TO) Maple Leaf Foods Reports Q1 Revenue $962.9M
$MFI.TO